Treatment of Cutaneous Squamous Cell Carcinoma With the Topical Histone Deacetylase Inhibitor Remetinostat

JAMA DERMATOLOGY（2022）

引用 3|浏览10

暂无评分

摘要

This case series study examines the use of the histone deacetylase inhibitor remetinostat in treating patients with squamous cell carcinoma.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要